Mergers and acquisitions have been a crucial part of the market for centuries. Oracle is set to embark on its biggest acquisition after agreeing to acquire Cerner.
Oracle to Acquire Cerner for Nearly $30 Billion
A report by the Wall Street Journal earlier today revealed that Oracle has agreed to acquire medical records company Cerner in a deal worth nearly $30 billion. This latest development would be the biggest acquisition in Oracle’s history.
The deal would be all in cash, with Cerner valued at $95 per share or $28.3 billion. The acquisition is expected to be finalized in 2022, allowing Oracle to boost its presence within the healthcare industry. The introduction of health data to its cloud services could make Oracle one of the biggest players in the healthcare sector.
This latest development comes at a time when mergers and acquisitions are increasingly becoming popular. 2021 is the first year that mergers and acquisitions surpassed $5 trillion globally, indicating a growing appetite for bigger companies to swallow the smaller ones.
The technology and healthcare sectors lead the global charge for mergers and acquisitions.
Oracle’s Stock Price Dips, Cerner Rallies
Following the announcement of the deal, the shares of the two companies have behaved differently. The shares of Oracle are down by more than 5% since the United States market opened a few hours ago.
At press time, ORCL is trading at $91.68, down by more than 5% over the past 24 hours. Despite the recent dip, ORCL has performed excellently since the start of the year. ORCL’s value has soared by more than 43% over the last 12 months.
CERN, on the other hand, has seen its value rise by more than 1% since the news was reported a few hours ago. The stock has performed excellently in recent months, rising by more than 16% since the start of 2021. At press time, CERN is trading at $90.48 per share.